Last update 14 Feb 2026

RX108-A

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
RX108-A
Target
Na/K-ATPase
Action
inhibitors
Mechanism
Na/K-ATPase inhibitors(Sodium/potassium-transporting ATPase inhibitors)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Colorectal CancerAdvanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Suzhou NeuPharma Co., Ltd.Suzhou NeuPharma Co., Ltd.
Active Organization
Suzhou NeuPharma Co., Ltd.Suzhou NeuPharma Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with RX108-A
CTR20243981
/ RecruitingPhase 1
RX108-A片在晚期恶性实体肿瘤患者中的安全性、耐受性、药代动力学和初步疗效的I期研究
[Translation] A Phase I study of the safety, tolerability, pharmacokinetics and preliminary efficacy of RX108-A tablets in patients with advanced malignant solid tumors
ACTRN12623000307606
/ RecruitingPhase 1
A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of RX108-A Tablet in Patients with Locally Advanced or Metastatic Solid Tumors
CTR20260497
/ Not yet recruitingPhase 2
RX108-A片在晚期结直肠癌患者中的有效性和安全性的II期临床研究
[Translation] A Phase II clinical study of the efficacy and safety of RX108-A tablets in patients with advanced colorectal cancer.
100 Clinical Results associated with RX108-A
Login to view more data
100 Translational Medicine associated with RX108-A
Login to view more data
100 Patents (Medical) associated with RX108-A
Login to view more data
100 Deals associated with RX108-A
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colorectal CancerPhase 2
China
Suzhou NeuPharma Co., Ltd.Suzhou NeuPharma Co., Ltd.
13 Feb 2026
Advanced Malignant Solid NeoplasmPhase 1
China
Suzhou NeuPharma Co., Ltd.Suzhou NeuPharma Co., Ltd.
09 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free